Disc Medicine, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number
Disc Medicine, Inc. (IRON) had Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of 0 shares as of 2024-06-30, per its 10-Q filed 2024-08-08.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber · last filed 2024-08-08
- 2024-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 0.00 shares.
- 2024-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 0.00 shares.
- 2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 0.00 shares.
- 2023-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 0.00 shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number as first filed |
|---|---|---|
| 2024-06-30 | 0.00 shares 10-Q · filed 2024-08-08 | |
| 2024-03-31 | 0.00 shares 10-Q · filed 2024-05-09 | |
| 2023-12-31 | 0.00 shares 10-Q · filed 2024-08-08 | |
| 2023-09-30 | 0.00 shares 10-Q · filed 2023-11-09 | |
| 2023-06-30 | 0.00 shares 10-Q · filed 2024-08-08 | |
| 2023-03-31 | 958.00 shares 10-Q · filed 2024-05-09 | |
| 2022-12-31 | 1.92K shares 10-Q · filed 2024-08-08 | |
| 2022-09-30 | 3.32K shares 10-Q · filed 2023-11-09 | |
| 2022-06-30 | 5.60K shares 10-Q · filed 2023-08-11 | |
| 2022-03-31 | 7.88K shares 10-Q · filed 2023-05-15 | |
| 2021-12-31 | 10.17K shares 10-K · filed 2024-03-21 | 1.25M shares 10-K · filed 2022-03-10 |
| 2020-12-31 | 24.94K shares 10-K · filed 2023-03-31 | 35.57K shares 10-K · filed 2022-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |